Back To Top

Exicon participates in paid-in capital increase of Sam CNS

[DISCLOSURE] Exicon (092870) said on July 4 that it bought 14 million shares, or 38.89 percent stakes, in Sam CNS, a Korean ceramic base material manufacturer, in a bid to secure a new growth engine by entering the materials business.




MOST POPULAR
LATEST NEWS
subscribe
지나쌤